Sigvant Birgitta, Hasvold Pål, Kragsterman Björn, Falkenberg Mårten, Johansson Saga, Thuresson Marcus, Nordanstig Joakim
Department of Vascular Surgery, Karlstad Central Hospital, Karlstad, Sweden; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institute, Stockholm, Sweden.
AstraZeneca Gothenburg, Mölndal, Sweden.
J Vasc Surg. 2017 Aug;66(2):507-514.e1. doi: 10.1016/j.jvs.2017.01.067. Epub 2017 Apr 19.
Long-term progression of peripheral arterial disease (PAD) as initial manifestation of atherosclerotic arterial disease is not well described. Cardiovascular (CV) risk was examined in different PAD populations diagnosed in a hospital setting in Sweden.
Data for this retrospective cohort study were retrieved by linking data on morbidity, medication use, and mortality from Swedish national registries. Primary CV outcome was a composite of myocardial infarction, ischemic stroke (IS), and CV death. Kaplan-Meier analysis and Cox proportional hazards modeling was used for describing risk and relative risk.
Of 66,189 patients with an incident PAD diagnosis (2006-2013), 40,136 had primary PAD, 16,786 had PAD + coronary heart disease (CHD), 5803 had PAD + IS, and 3464 had PAD + IS + CHD. One-year cumulative incidence rates of major CV events for the groups were 12%, 21%, 29%, and 34%, respectively. Corresponding numbers for 1-year all-cause death were 16%, 22%, 33%, and 35%. Compared with the primary PAD population, the relative risk increase for CV events was highest in patients with PAD + IS + CHD (hazard ratio [HR], 2.01), followed by PAD + IS (HR, 1.87) and PAD + CHD (HR, 1.42). Despite being younger, the primary PAD population was less intensively treated with secondary preventive drug therapy.
PAD as initial manifestation of atherosclerotic disease diagnosed in a hospital-based setting conferred a high risk: one in eight patients experienced a major CV event and one in six patients died within 1 year. Despite younger age and substantial risk of future major CV events, patients with primary PAD received less intensive secondary preventive drug therapy.
外周动脉疾病(PAD)作为动脉粥样硬化性疾病的初始表现,其长期进展情况尚未得到充分描述。我们对瑞典一家医院确诊的不同PAD人群的心血管(CV)风险进行了研究。
通过将瑞典国家登记处的发病率、用药情况和死亡率数据相链接,获取了这项回顾性队列研究的数据。主要CV结局是心肌梗死、缺血性中风(IS)和CV死亡的复合结局。采用Kaplan-Meier分析和Cox比例风险模型来描述风险和相对风险。
在66189例首次诊断为PAD的患者(2006 - 2013年)中,40136例为原发性PAD,16786例为PAD + 冠心病(CHD),5803例为PAD + IS,3464例为PAD + IS + CHD。这些组的主要CV事件1年累积发生率分别为12%、21%、29%和34%。1年全因死亡的相应数字分别为16%、22%、33%和35%。与原发性PAD人群相比,PAD + IS + CHD患者发生CV事件的相对风险增加最高(风险比[HR],2.01),其次是PAD + IS(HR,1.87)和PAD + CHD(HR,1.42)。尽管原发性PAD人群年龄较轻,但接受二级预防药物治疗的强度较低。
在医院环境中诊断为动脉粥样硬化疾病初始表现的PAD具有高风险:八分之一的患者发生了主要CV事件,六分之一的患者在1年内死亡。尽管年龄较轻且未来发生重大CV事件的风险很高,但原发性PAD患者接受的二级预防药物治疗强度较低。